Ensysce Biosciences ENSC
NASDAQ ENSC
$0.36 +0.00 (+1.41%)
As of: Nov 10, 2026 · 3:14 PM EST

Ensysce Biosciences (ENSC) EBITDA (2020 - 2021)

Updated

Ensysce Biosciences (ENSC) reported EBITDA of -$2.01 million for Q4 2021, compared with -$1.09 million a year earlier.

Analysis

Ensysce Biosciences (ENSC) EBITDA (2020 - 2021) Analysis & Trends

For FY2021, Ensysce Biosciences posted EBITDA of -$19.87 million.

  • By year, EBITDA came in at -$1.61 million in FY2020.
  • Five-year quarterly EBITDA spans a low of -$16.89 million in Q3 2021 and a high of $139,131 in Q2 2020.
  • Per Business Quant data, the three quarters before Q4 2021 came in at -$16.89 million (Q3 2021), -$412,567 (Q2 2021) and -$524,222 (Q1 2021).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) EBITDA (Qtr)
1 Eli Lilly 1,264.65 Bn 1,238.27 Bn 20.46 Bn 13.33 Bn
2 Johnson & Johnson 677.74 Bn 597.60 Bn 17.30 Bn 8.30 Bn
3 AbbVie 517.10 Bn 485.11 Bn 13.12 Bn 8.16 Bn
4 Merck 362.23 Bn 325.17 Bn 13.19 Bn 7.37 Bn
5 Novartis Ag 315.90 Bn 276.16 Bn 11.24 Bn -
6 Astrazeneca 289.40 Bn 266.24 Bn 12.86 Bn -
7 Amgen 249.90 Bn 201.56 Bn 7.58 Bn 4.83 Bn
8 Gilead Sciences 209.15 Bn 184.26 Bn 6.73 Bn 4.20 Bn
9 Pfizer 165.88 Bn 113.23 Bn 12.56 Bn 7.05 Bn
10 Ensysce Biosciences 901,219.67 -10.35 Mn - -
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2021 -2.01 Mn
Sep 30, 2021 -16.89 Mn
Jun 30, 2021 -412,567.00
Mar 31, 2021 -524,222.00
Dec 31, 2020 -1.09 Mn
Sep 30, 2020 -404,724.00
Jun 30, 2020 327,703.00
API Access

Ensysce Biosciences EBITDA API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=ebitda&ticker=ENSC&period=max&api_key=YOUR_API_KEY